Aduro BioTech secures $19.25 million in Series B financing - MarketLine Financial Deals

Aduro BioTech secures $19.25 million in Series B financing

Aduro BioTech secures $19.25 million in Series B financing - MarketLine Financial Deals
Aduro BioTech secures $19.25 million in Series B financing
Published Apr 20, 2011
2 pages — Published Apr 20, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Aduro BioTech, Inc., a US-based developer of immunotherapies for infectious diseases and cancer, has secured $19.25 million in Series B financing.

  
Source:
Document ID
MA59417_110421
Country
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Aduro BioTech secures $19.25 million in Series B financing" Apr 20, 2011. Alacra Store. Dec 05, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Aduro-BioTech-secures-19-25-million-in-Series-B-financing-2052-59796>
  
APA:
MarketLine Financial Deals. (2011). Aduro BioTech secures $19.25 million in Series B financing Apr 20, 2011. New York, NY: Alacra Store. Retrieved Dec 05, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Aduro-BioTech-secures-19-25-million-in-Series-B-financing-2052-59796>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.